Jouko Levijoki

2.1k total citations
44 papers, 1.6k citations indexed

About

Jouko Levijoki is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jouko Levijoki has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 20 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Jouko Levijoki's work include Cardiac electrophysiology and arrhythmias (19 papers), Ion channel regulation and function (11 papers) and Heart Failure Treatment and Management (11 papers). Jouko Levijoki is often cited by papers focused on Cardiac electrophysiology and arrhythmias (19 papers), Ion channel regulation and function (11 papers) and Heart Failure Treatment and Management (11 papers). Jouko Levijoki collaborates with scholars based in Finland, Hungary and United Kingdom. Jouko Levijoki's co-authors include Heimo Haikala, Piero Pollesello, Petri Kaheinen, Piet Finckenberg, Eero Mervaala, Erkki Nissinen, Inge‐Britt Lindén, Saara Merasto, Zoltán Papp and István Édes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Hypertension.

In The Last Decade

Jouko Levijoki

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jouko Levijoki Finland	21	979	577	208	196	161	44	1.6k
Jiyoong Kim Japan	27	1.0k 1.0×	601 1.0×	317 1.5×	249 1.3×	67 0.4×	68	1.9k
Masashi Fujita Japan	19	1.0k 1.1×	473 0.8×	232 1.1×	391 2.0×	60 0.4×	62	2.0k
Harald Kögler Germany	21	786 0.8×	608 1.1×	117 0.6×	138 0.7×	62 0.4×	45	1.4k
Hiroyuki Takahama Japan	20	1.0k 1.1×	410 0.7×	129 0.6×	230 1.2×	64 0.4×	66	1.7k
Peter Luedike Germany	20	466 0.5×	528 0.9×	130 0.6×	286 1.5×	182 1.1×	88	2.0k
Bruce G. Hook United States	17	1.2k 1.2×	371 0.6×	591 2.8×	274 1.4×	83 0.5×	43	2.2k
Lisa C. Costello‐Boerrigter United States	24	1.7k 1.7×	451 0.8×	59 0.3×	326 1.7×	115 0.7×	59	2.3k
Xiaomang You Canada	19	481 0.5×	491 0.9×	178 0.9×	292 1.5×	61 0.4×	29	1.5k
Kazuhira Maehara Japan	15	674 0.7×	461 0.8×	264 1.3×	208 1.1×	48 0.3×	50	1.3k
Brian S. Cain United States	23	655 0.7×	555 1.0×	700 3.4×	307 1.6×	108 0.7×	38	1.9k

Countries citing papers authored by Jouko Levijoki

Since Specialization

Citations

This map shows the geographic impact of Jouko Levijoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jouko Levijoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jouko Levijoki more than expected).

Fields of papers citing papers by Jouko Levijoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jouko Levijoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jouko Levijoki. The network helps show where Jouko Levijoki may publish in the future.

Co-authorship network of co-authors of Jouko Levijoki

This figure shows the co-authorship network connecting the top 25 collaborators of Jouko Levijoki. A scholar is included among the top collaborators of Jouko Levijoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jouko Levijoki. Jouko Levijoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pollesello, Piero, Jouko Levijoki, & Zoltán Papp. (2025). Chronotropic Effects of Milrinone in a Guinea Pig Ex Vivo Model: A Pilot Study to Screen for New Mechanisms of Action. Journal of Cardiovascular Pharmacology. 85(4). 278–286.

Levijoki, Jouko, et al.. (2023). Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting. Journal of Pharmacology and Experimental Therapeutics. 384(3). 439–444. 1 indexed citations

Levijoki, Jouko, et al.. (2023). An experimental study of consecutive administration of ropinirole and apomorphine for emesis induction in dogs. Journal of Veterinary Emergency and Critical Care. 34(1). 31–39. 1 indexed citations

Loewe, Axel, Zsófia Kohajda, Jouko Levijoki, et al.. (2022). The reverse mode of the Na+/Ca2+ exchanger contributes to the pacemaker mechanism in rabbit sinus node cells. Scientific Reports. 12(1). 21830–21830. 4 indexed citations

Kohajda, Zsófia, Axel Loewe, János Prorok, et al.. (2020). Novel Na+/Ca2+ Exchanger Inhibitor ORM-10962 Supports Coupled Function of Funny-Current and Na+/Ca2+ Exchanger in Pacemaking of Rabbit Sinus Node Tissue. Frontiers in Pharmacology. 10. 1632–1632. 10 indexed citations

Primeßnig, Uwe, Jouko Levijoki, Piero Pollesello, et al.. (2019). Long-Term Effects of Na+/Ca2+ Exchanger Inhibition with ORM-11035 Improves Cardiac Function and Remodelling without Lowering Blood Pressure in a Model of Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 21(12). 1543–1552. 20 indexed citations

Hegyi, Bence, Julie Bossuyt, Leigh G. Griffiths, et al.. (2018). Complex electrophysiological remodeling in postinfarction ischemic heart failure. Proceedings of the National Academy of Sciences. 115(13). E3036–E3044. 69 indexed citations

Grüber, Andrea, Zoltán Márton, Zsófia Kohajda, et al.. (2017). Inotropic effect of NCX inhibition depends on the relative activity of the reverse NCX assessed by a novel inhibitor ORM-10962 on canine ventricular myocytes. European Journal of Pharmacology. 818. 278–286. 8 indexed citations

Nagy, László, Piero Pollesello, Heimo Haikala, et al.. (2016). ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy. European Journal of Pharmacology. 775. 120–129. 4 indexed citations

10.

Nagy, Norbert, Károly Acsai, Piero Pollesello, et al.. (2014). Efficacy of selective NCX inhibition by ORM-10103 during simulated ischemia/reperfusion. European Journal of Pharmacology. 740. 539–551. 14 indexed citations

11.

Finckenberg, Piet, et al.. (2014). Dexmedetomidine preconditioning ameliorates kidney ischemia‐reperfusion injury. Pharmacology Research & Perspectives. 2(3). e00045–e00045. 68 indexed citations

12.

Tilgmann, Carola, Piero Pollesello, Martti Ovaska, et al.. (2012). Discovery and Structural Characterization of a Phospholamban‐Binding Cyclic Peptide and Design of Novel Inhibitors of Phospholamban. Chemical Biology & Drug Design. 81(4). 463–473. 4 indexed citations

13.

Finckenberg, Piet, et al.. (2012). AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney. British Journal of Pharmacology. 166(6). 1905–1915. 108 indexed citations

14.

Louhelainen, Marjut, Saara Merasto, Piet Finckenberg, et al.. (2010). Effects of the calcium sensitizer OR‐1896, a metabolite of levosimendan, on post‐infarct heart failure and cardiac remodelling in diabetic Goto–Kakizaki rats. British Journal of Pharmacology. 160(1). 142–152. 7 indexed citations

15.

Louhelainen, Marjut, Saara Merasto, Ville Kytö, et al.. (2009). Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats. Journal of Hypertension. 27(10). 2094–2107. 20 indexed citations

16.

Masutani, Satoshi, Heng-Jie Cheng, Jouko Levijoki, et al.. (2008). Orally Available Levosimendan Dose-Related Positive Inotropic and Lusitropic Effect in Conscious Chronically Instrumented Normal and Heart Failure Dogs. Journal of Pharmacology and Experimental Therapeutics. 325(1). 236–247. 10 indexed citations

17.

Louhelainen, Marjut, Petri Kaheinen, Hanna Leskinen, et al.. (2007). Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. British Journal of Pharmacology. 150(7). 851–861. 63 indexed citations

18.

Pollesello, Piero, Jouko Levijoki, Petri Kaheinen, et al.. (2004). The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. European Journal of Pharmacology. 486(1). 67–74. 96 indexed citations

19.

Kaheinen, Petri, Piero Pollesello, Jouko Levijoki, & Heimo Haikala. (2001). Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels. Journal of Cardiovascular Pharmacology. 37(4). 367–374. 129 indexed citations

20.

Levijoki, Jouko, Piero Pollesello, Juha Kaivola, et al.. (2000). Further Evidence for the Cardiac Troponin C Mediated Calcium Sensitization by Levosimendan: Structure-response and Binding Analysis with Analogs of Levosimendan. Journal of Molecular and Cellular Cardiology. 32(3). 479–491. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact